Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Developments in oral enterotoxigenic Escherichia coli vaccines

29 Jul 2023

Abstract excerpt

Enterotoxigenic Escherichia coli (ETEC) is a leading cause of diarrhea in children in developing countries and in travelers. WHO has affirmed ETEC as a priority vaccine target, but there is no licensed ETEC vaccine available yet. We here describe recent, promising developments of different live, inactivated, and subunit ETEC candidate vaccines expressing or containing nontoxic enterotoxin and/or colonization...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Escherichia coli research studies
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37523966
DOI: 10.1016/j.coi.2023.102372

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Developments in oral enterotoxigenic Escherichia coli vaccinesPMID 37523966Read ↗

Vaccines Against Shigella and Enterotoxigenic Escherichia coli: A summary of the 2018 VASE ConferenceSemantic proximity Read ↗

Confronting Challenges to Enterotoxigenic Escherichia coli Vaccine DevelopmentSemantic proximity Read ↗

Targeting Enterotoxins: Advancing Vaccine Development for Enterotoxigenic Escherichia coli ETECSemantic proximity Read ↗

Vaccine value profile for enterotoxigenic Escherichia coli (ETEC)Semantic proximity Read ↗

Generation and Characterization of a Live Attenuated Enterotoxigenic Escherichia coli Combination Vaccine Expressing Six Colonization Factors and Heat-Labile Toxin Subunit BSemantic proximity Read ↗

Potential for a Combined Oral Inactivated Whole-Cell Vaccine Against ETEC and Shigella: Preclinical Studies Supporting FeasibilitySemantic proximity Read ↗

Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) diseaseSemantic proximity Read ↗

Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans.Semantic proximity Read ↗

Emerging Themes in the Molecular Pathogenesis of Enterotoxigenic Escherichia coliSemantic proximity Read ↗

Heat-Stable Enterotoxins of Enterotoxigenic Escherichia coli and Their Impact on Host ImmunitySemantic proximity Read ↗

Randomized clinical trial assessing the safety and immunogenicity of oral microencapsulated enterotoxigenic Escherichia coli surface antigen 6 with or without heat-labile enterotoxin with mutation R192G.Semantic proximity Read ↗

Interrogation of a live-attenuated enterotoxigenic Escherichia coli vaccine highlights features unique to wild-type infectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.